207 related articles for article (PubMed ID: 8164384)
1. [Clinical usefulness of pharmacological treatment of Cushing's syndrome].
Saito J; Nishikawa T
Nihon Rinsho; 1994 Mar; 52(3):793-6. PubMed ID: 8164384
[TBL] [Abstract][Full Text] [Related]
2. [Medical treatment for Cushing's syndrome].
Nishikawa T; Saito J; Omura M
Nihon Rinsho; 2008 Jan; 66(1):186-91. PubMed ID: 18186263
[TBL] [Abstract][Full Text] [Related]
3. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
Engelhardt D; Weber MM
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
[TBL] [Abstract][Full Text] [Related]
4. Drugs in the medical treatment of Cushing's syndrome.
Schteingart DE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
[TBL] [Abstract][Full Text] [Related]
5. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
Feelders RA; Hofland LJ; de Herder WW
Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
[TBL] [Abstract][Full Text] [Related]
7. Cushing's syndrome.
Schteingart DE
Endocrinol Metab Clin North Am; 1989 Jun; 18(2):311-38. PubMed ID: 2663477
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of Cushing's syndrome with aminoglutethimide and ketoconazole.
Kong HL; Lee KO; Cheah JS
Singapore Med J; 1992 Oct; 33(5):523-4. PubMed ID: 1455284
[TBL] [Abstract][Full Text] [Related]
9. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
[TBL] [Abstract][Full Text] [Related]
10. Management of diabetes mellitus in Cushing's syndrome.
Munir A; Newell-Price J
Neuroendocrinology; 2010; 92 Suppl 1():82-5. PubMed ID: 20829624
[TBL] [Abstract][Full Text] [Related]
11. [The long-term therapy of hypothalamic-hypophyseal Cushing's syndrome with mitotane (o,p'-DDD)].
Knappe G; Gerl H; Ventz M; Rohde W
Dtsch Med Wochenschr; 1997 Jul; 122(28-29):882-6. PubMed ID: 9264918
[TBL] [Abstract][Full Text] [Related]
12. Steroid biosynthesis inhibitors in Cushing's syndrome.
Engelhardt D
Clin Investig; 1994 Jul; 72(7):481-8. PubMed ID: 7981573
[No Abstract] [Full Text] [Related]
13. [Multiple recurrence of Cushing's syndrome after bilateral adrenalectomy and pituitary gland surgery. Cure with o,p'-DDD].
Bigler U; Müller J
Schweiz Med Wochenschr; 1978 Jan; 108(2):67-72. PubMed ID: 622536
[TBL] [Abstract][Full Text] [Related]
14. Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing's syndrome.
Daniel E; Newell-Price JD
Eur J Endocrinol; 2015 Jun; 172(6):R263-80. PubMed ID: 25637072
[TBL] [Abstract][Full Text] [Related]
15. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
[TBL] [Abstract][Full Text] [Related]
16. [Medical treatment of Cushing syndrome].
Mantero F; Sonino N
Minerva Endocrinol; 1990; 15(1):17-21. PubMed ID: 2274010
[TBL] [Abstract][Full Text] [Related]
17. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
Thorén M; Adamson U; Sjöberg HE
Acta Endocrinol (Copenh); 1985 Aug; 109(4):451-7. PubMed ID: 3898689
[TBL] [Abstract][Full Text] [Related]
18. Plasma level monitoring of mitotane (o,p'-DDD) and its metabolite (o,p'-DDE) during long-term treatment of Cushing's disease with low doses.
Benecke R; Keller E; Vetter B; de Zeeuw RA
Eur J Clin Pharmacol; 1991; 41(3):259-61. PubMed ID: 1748144
[TBL] [Abstract][Full Text] [Related]
19. [The effects of o,p'-DDD on human adrenal steroid synthesis].
Ojima M; Saito M; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):852-71. PubMed ID: 6094274
[TBL] [Abstract][Full Text] [Related]
20. Effect of o,p'-DDD on plasma ACTH concentration in Cushing's disease.
Bruno OD; Hoschoian JC; Andrada JA
Medicina (B Aires); 1979; 39(2):229-34. PubMed ID: 228150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
